Add to ORKGBackground: The coronary slow flow phenomenon (CSFP) is a coronary microvascular disorder angiographically defined by delayed opacification of the distal vasculature in the absence of obstructive coronary artery disease. We aimed to investigate and compare the effects of intracoronary nitrate and diltiazem on thrombolysis in myocardial infarction frame count (TFC) in patients with CSFP during coronary angiography
Background: The coronary slow flow phenomenon (CSFP) is an angiographic finding characterized by del...
OBJECTIVE: The aim of this study is to observe the chronic effects of diltiazem release capsules on ...
Objective: The aim of this study is to observe the chronic effects of diltiazem release capsules on ...
Background: The coronary slow flow phenomenon (CSFP) is a coronary microvascular disorder angiograph...
Copyright © 2007 Elsevier B.V. All rights reserved.The coronary slow flow phenomenon (CSFP) is a mic...
Copyright © 2003 Mosby, Inc. All rights reserved.Background - The coronary slow flow phenomenon (CSF...
We investigated myocardial perfusion in acute patients with slow coronary flow (SCF) at angiography....
The aim of this study is to observe the chronic effects of diltiazem release capsules on patients wi...
The exact etiology of the coronary slow flow phenomenon (CSFP) is not certain. CSFP is not a normal ...
We investigated myocardial perfusion in acute patients with slow coronary flow (SCF) at angiography....
The coronary slow flow phenomenon (CSFP) is associated with coronary microvascular dysfunction altho...
Background . Coronary slow-flow phenomenon (CSFP) is characterized by delayed distal vessel opacific...
Coronary slow flow phenomenon (CSFP) is characterized by delayed progression of the contrast medium ...
BackgroundCoronary slow flow phenomenon (CSFP) is characterized by delayed progression of the contra...
Coronary slow flow (CSF) phenomenon, also known as cardiac syndrome Y, is defined as the delayed opa...
Background: The coronary slow flow phenomenon (CSFP) is an angiographic finding characterized by del...
OBJECTIVE: The aim of this study is to observe the chronic effects of diltiazem release capsules on ...
Objective: The aim of this study is to observe the chronic effects of diltiazem release capsules on ...
Background: The coronary slow flow phenomenon (CSFP) is a coronary microvascular disorder angiograph...
Copyright © 2007 Elsevier B.V. All rights reserved.The coronary slow flow phenomenon (CSFP) is a mic...
Copyright © 2003 Mosby, Inc. All rights reserved.Background - The coronary slow flow phenomenon (CSF...
We investigated myocardial perfusion in acute patients with slow coronary flow (SCF) at angiography....
The aim of this study is to observe the chronic effects of diltiazem release capsules on patients wi...
The exact etiology of the coronary slow flow phenomenon (CSFP) is not certain. CSFP is not a normal ...
We investigated myocardial perfusion in acute patients with slow coronary flow (SCF) at angiography....
The coronary slow flow phenomenon (CSFP) is associated with coronary microvascular dysfunction altho...
Background . Coronary slow-flow phenomenon (CSFP) is characterized by delayed distal vessel opacific...
Coronary slow flow phenomenon (CSFP) is characterized by delayed progression of the contrast medium ...
BackgroundCoronary slow flow phenomenon (CSFP) is characterized by delayed progression of the contra...
Coronary slow flow (CSF) phenomenon, also known as cardiac syndrome Y, is defined as the delayed opa...
Background: The coronary slow flow phenomenon (CSFP) is an angiographic finding characterized by del...
OBJECTIVE: The aim of this study is to observe the chronic effects of diltiazem release capsules on ...
Objective: The aim of this study is to observe the chronic effects of diltiazem release capsules on ...